Robert Moritz and colleagues at the Institute for Systems Biology and Seattle Biomed in the U.S. will use ultra-sensitive targeted assay technology to identify, quantify, and validate a library of biomarker candidates specific to both active and latent TB infection. Moritz and his team hope to discover highly specific proteins that could help determine disease status at the point of care and inform appropriate treatment.
Grant ID
TBBiomarkers9 - OPP1039684
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Challenge
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
2207191.00
Funding Currency
USD
Funding Amount (in USD)
2207191.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
2207191.00
Co-Funded
False